Core Viewpoint - Hengyun Chang, a key supplier of semiconductor equipment core components, has successfully listed on the Sci-Tech Innovation Board, with its stock price surging significantly on the first day of trading, indicating strong market interest and confidence in its growth potential [1][2]. Company Overview - Hengyun Chang was established in March 2013 and is recognized as a leading domestic manufacturer of plasma radio frequency power systems, achieving mass production of semiconductor-grade systems [4][36]. - The company has been awarded the title of "Little Giant" enterprise by the state, highlighting its specialized and innovative capabilities in the semiconductor sector [4]. Market Position - Hengyun Chang holds the largest market share among domestic manufacturers of plasma radio frequency power systems, which are critical components in semiconductor equipment [4]. - The company has successfully broken the long-standing monopoly of two major American companies, MKS and AE, in the domestic market [4]. Financial Performance - The company reported revenues of 1.58 billion, 3.25 billion, 5.41 billion, and 3.04 billion from 2022 to the first half of 2025, with net profits of 0.26 billion, 0.80 billion, 1.42 billion, and 0.69 billion respectively [12]. - The gross profit margin for Hengyun Chang's main business has shown a steady increase, reaching 49.01% in the first half of 2025, comparable to MKS [16][17]. Product Development - Hengyun Chang has developed three generations of plasma radio frequency power systems, with the latest products supporting advanced semiconductor processes of 7-14nm [12][8]. - The company has delivered products to leading domestic semiconductor equipment manufacturers, including TuoJing Technology and Zhongwei Company, and has established itself as a strategic supplier [22][24]. Research and Development - As of June 30, 2025, Hengyun Chang employed 158 R&D personnel, accounting for 42.13% of its total workforce, and holds 108 authorized invention patents [19][20]. - The company has focused on developing core technologies that enhance the performance and reliability of its products, aiming to meet the demands of advanced semiconductor manufacturing [21]. Customer Base - The top five customers contributed significantly to Hengyun Chang's revenue, with TuoJing Technology being the largest, accounting for over 62% of sales in recent years [23]. - The company has achieved substantial revenue growth from its key clients, with notable increases in sales to Zhongwei Company and BeiFang HuaChuang [25]. Future Prospects - Hengyun Chang plans to use the proceeds from its IPO, totaling 15.61 billion, to fund the industrialization of its semiconductor radio frequency power systems in Shenyang [6]. - The company aims to further enhance its market position and expand its product offerings to meet the growing demand in the semiconductor industry [36].

Core Viewpoint - This week, there are two new stocks available for subscription: one on the Beijing Stock Exchange and one on the Sci-Tech Innovation Board [1][6]. Group 1: Aishalun - Aishalun is the largest manufacturer of medical care pads in China [2][7]. - The issue price of Aishalun is 15.98 yuan per share, with a price-to-earnings ratio of 14.99 times [3][8]. - Aishalun focuses on the medical health sector, specializing in the research, production, and sales of disposable medical consumables for rehabilitation and medical protection [3][8]. - The company has shown rapid growth, with revenues of 574 million yuan, 575 million yuan, and 692 million yuan from 2022 to 2024, and net profits of 63 million yuan, 67 million yuan, and 81 million yuan for the same years [3][8]. - For 2025, Aishalun's management forecasts a revenue growth of 28.65% to 35.89% and a net profit growth of 10.63% to 22.01% [3][8]. Group 2: Hengyunchang - Hengyunchang is a leading supplier of core components for semiconductor equipment in China [4][9]. - The public offering will consist of 16.93 million shares, with a maximum subscription limit of 4,000 shares for online investors [4][9]. - Hengyunchang is recognized as having the highest market share among domestic plasma RF power system manufacturers in 2024 [4][9]. - The company has established strategic partnerships with major semiconductor equipment manufacturers, becoming a core supplier in critical processes such as film deposition and etching [4][9]. - From 2022 to 2024, Hengyunchang's revenues were 158 million yuan, 325 million yuan, and 541 million yuan, with net profits of 26 million yuan, 80 million yuan, and 142 million yuan [4][9]. - For 2025, the company anticipates a revenue decline of 4.69% to 9.58% and a net profit decline of 19.54% to 28.21% [4][9]. Group 3: Market Overview - In 2025, a total of 19 new stocks will be listed on the Sci-Tech Innovation Board, bringing the total number of companies to 600 [5][10]. - All 19 new stocks experienced price increases on their first trading day, with an average increase of 244.37%, and 18 of them saw gains exceeding 100% [5][10]. - The most recent listing was Qiangyi Co., a leading domestic semiconductor probe card company, which had an issue price of 85.09 yuan per share and a first-day increase of 165.61%, resulting in a profit of 70,500 yuan per subscription [5][10].

Core Viewpoint - The article discusses the upcoming IPOs of two companies, Aisheren and Hengyun Chang, highlighting their business focus, financial performance, and market positions. Group 1: Aisheren - Aisheren is the largest manufacturer of medical care pads in China, focusing on disposable medical consumables for rehabilitation and medical protection [2][7] - The IPO price for Aisheren is set at 15.98 CNY per share, with a price-to-earnings ratio of 14.99 [2][7] - Aisheren's revenue for 2022, 2023, and 2024 is projected to be 574 million CNY, 575 million CNY, and 692 million CNY, respectively, with net profits of 63 million CNY, 67 million CNY, and 81 million CNY [2][7] - The company forecasts a revenue growth of 28.65% to 35.89% and a net profit growth of 10.63% to 22.01% for 2025 [2][7] Group 2: Hengyun Chang - Hengyun Chang is a leading supplier of core components for semiconductor equipment, focusing on plasma RF power systems and related technologies [3][8] - The company plans to issue 16.93 million shares, with a maximum subscription limit of 4,000 shares for online investors [3][8] - Hengyun Chang's revenue for 2022, 2023, and 2024 is projected to be 158 million CNY, 325 million CNY, and 541 million CNY, respectively, with net profits of 26 million CNY, 80 million CNY, and 142 million CNY [3][8] - The company anticipates a revenue decline of 4.69% to 9.58% and a net profit decline of 19.54% to 28.21% for 2025 [3][8] Group 3: Market Context - In 2025, a total of 19 new stocks are expected to be listed on the Sci-Tech Innovation Board, bringing the total number of companies to 600 [4][9] - All 19 new stocks listed in 2025 experienced price increases on their first trading day, with an average increase of 244.37%, and 18 of them saw gains exceeding 100% [4][9] - The most recent listing, Qiangyi Co., had an IPO price of 85.09 CNY per share and a first-day increase of 165.61%, resulting in a profit of 70,500 CNY for a single subscription [4][9]

Core Viewpoint - The A-share market will have two new stocks available for subscription next week, including Aisheren and Hengyun Chang, with Hengyun Chang being a leading supplier of core components for semiconductor equipment [1][2] Group 1: Aisheren - Aisheren's issue price is set at 15.98 yuan per share, focusing on the medical health sector, particularly in disposable medical consumables for rehabilitation and medical protection [1] - Aisheren is the largest manufacturer of medical care pads in China and a leading exporter of medical dressings [1] - The company expects to achieve total revenue of 691.64 million yuan and a net profit of 80.71 million yuan in 2024, with projected revenue growth of 28.65% to 35.89% in 2025 [1] Group 2: Hengyun Chang - Hengyun Chang is recognized for its plasma radio frequency power systems, which are considered a critical component in the semiconductor equipment supply chain, facing high technical barriers and requiring significant R&D investment [2] - The company has successfully launched three product series, breaking the long-standing monopoly of two major American companies, MKS and AE, in the domestic market [2] - From 2022 to 2024, Hengyun Chang's revenue is projected to grow from 158 million yuan to 541 million yuan, with net profit increasing from 20 million yuan to 129 million yuan, indicating strong growth potential [2] - The company plans to raise 1.469 billion yuan for projects aimed at expanding production capacity, enhancing R&D, and improving customer support services [1][2]

Group 1 - The core viewpoint of the news is that the company is expanding its semiconductor-related operations through various projects aimed at enhancing production capacity and technological innovation in the semiconductor industry [1][5]. - The "Shenyang Semiconductor RF Power System Industrialization Construction Project" aims to establish a subsidiary in Shenyang to produce and sell semiconductor-grade plasma RF power systems, enhancing the company's presence in northern China [1]. - The "Intelligent Production Operation Base for Core Components of Semiconductor and Vacuum Equipment" and "R&D and Frontier Technology Innovation Center Project" will expand the product range and improve existing products based on customer needs, targeting sectors like photovoltaics and precision optics [1]. Group 2 - The "Marketing and Technical Support Center Project" will establish centers in key regions to provide customized technical services and improve communication with end wafer fabs, enhancing production efficiency and brand influence [2]. - The company is a leading domestic supplier of core components for semiconductor equipment, focusing on the development, production, and sales of plasma RF power systems and related technologies [4][5]. - The company plans to increase investment in R&D to promote the localization of semiconductor equipment core components, aiming to enhance the resilience and security of China's semiconductor supply chain [5]. Group 3 - The company reported a total investment of approximately 151.82 million, with significant allocations for various projects, including 69 million for the intelligent production operation base and 36.27 million for the R&D center [4]. - The company achieved a revenue of 5.408 billion in 2022, with a projected growth rate of 105.66% for the following year [7]. - The company’s R&D investment in 2024 was 55.28 million, representing a year-on-year increase of 49.55%, with R&D expenditure accounting for 10.22% of total revenue [49].

Group 1: IPO Approval and Fundraising - The Shanghai Stock Exchange and Beijing Stock Exchange approved the IPO applications of Hengyun Chang and Nongda Technology, with a total fundraising target of 1.882 billion yuan [1] - Hengyun Chang reduced its fundraising target from 1.55 billion yuan to 1.469 billion yuan, while Nongda Technology decreased its target from 552 million yuan to 413 million yuan [2][4] Group 2: Company Profiles - Hengyun Chang is a leading domestic supplier of core components for semiconductor equipment, focusing on the research, production, and sales of plasma RF power systems and related technologies [5][8] - The company has achieved significant milestones, including being the first domestic manufacturer to deliver plasma RF power systems supporting advanced semiconductor processes, with a market share leading among domestic competitors [8][9] - Nongda Technology specializes in the research, production, and sales of new fertilizers and their intermediates, holding a strong market position in the industry [17][18] Group 3: Financial Performance - Hengyun Chang reported revenues of 158 million yuan, 325 million yuan, 541 million yuan, and 304 million yuan from 2022 to the first half of 2025, with net profits of 19.61 million yuan, 68.53 million yuan, 129 million yuan, and 64.76 million yuan respectively [11] - Nongda Technology's revenues for the same period were 2.676 billion yuan, 2.637 billion yuan, 2.363 billion yuan, and 1.495 billion yuan, with net profits of 101.16 million yuan, 101.22 million yuan, 145.28 million yuan, and 125.65 million yuan [20][21] Group 4: Fund Utilization Plans - Hengyun Chang plans to use the raised funds for projects including the industrialization of semiconductor RF power systems, a smart production base for core components, and a research and innovation center [13] - Nongda Technology intends to allocate its funds towards the production of high tower compound fertilizers, a biological fertilizer production line, and a low-carbon biological research center [22]

Core Viewpoint - The Shanghai Stock Exchange will review the IPO application of Shenzhen Hengyun Chang Vacuum Technology Co., Ltd. on November 14, 2025, highlighting its position as a leading supplier of core components for semiconductor equipment in China [1] Company Overview - Hengyun Chang specializes in plasma technology, offering a product matrix that includes plasma RF power systems, plasma excitation devices, DC power supplies, and related accessories [2] - The company has achieved significant revenue from its semiconductor-grade plasma RF power systems, which have been recognized for their performance in the market [2] - As of the end of the reporting period, Hengyun Chang holds 108 authorized invention patents and has 133 invention patents pending [3] Market Position - According to Frost & Sullivan, the market size for plasma RF power systems in China's semiconductor industry is projected to reach 6.56 billion yuan in 2024, with Hengyun Chang holding the largest market share among domestic manufacturers [2] R&D and Innovation - Hengyun Chang has maintained high R&D investment, with expenditures of 21.54 million yuan, 36.96 million yuan, and 55.28 million yuan from 2022 to 2024, representing over 10% of revenue [4] - The company has developed a comprehensive technology system focused on the requirements of plasma RF power systems, achieving significant advancements in key technologies [4] Financial Performance - The company's revenue has grown rapidly, with figures of 158.16 million yuan, 325.27 million yuan, and 540.79 million yuan from 2022 to 2024, reflecting a compound annual growth rate (CAGR) of 84.91% [5] - Net profit attributable to shareholders has also seen substantial growth, with amounts of 26.19 million yuan, 79.83 million yuan, and 141.54 million yuan during the same period, resulting in a CAGR of 131.87% [5] Future Outlook - Hengyun Chang aims to capitalize on the opportunities presented by the domestic semiconductor industry and plans to enhance its product offerings and market share through continuous innovation and superior service [5]

Core Viewpoint - Shenzhen Hengyun Chang Vacuum Technology Co., Ltd. (Hengyun Chang) is progressing smoothly in its IPO process, with the listing review scheduled for November 14, 2025, after being accepted on June 13, 2023 [1][3] Company Overview - Hengyun Chang is a leading domestic supplier of core components for semiconductor equipment, focusing on the research, production, sales, and technical services of plasma RF power systems, plasma excitation devices, and related core components [3] - The company aims to create a core component platform to serve the high-end equipment manufacturing industry, emphasizing technological and product innovation [3] Performance Trends - Despite a steady increase in revenue and profit from 2022 to 2024, the company is experiencing a decline in performance in 2025 [4] - In the first half of 2025, Hengyun Chang's revenue grew by 4.06%, but net profit attributable to the parent company decreased by 11.99% [6] - The company forecasts a revenue decline of 4.69% to 9.58% and a net profit drop of 21.76% to 30.26% for the full year 2025 [6] Customer Dependency - Hengyun Chang has a high customer concentration, with the top five clients accounting for 73.54% to 90.62% of its main business revenue [7] - The first major client, Tuojing Technology, represents over 60% of the company's sales, indicating a significant dependency [7] Accounts Receivable Issues - The company has extended the payment terms for Tuojing Technology from 30 days to 60 days, leading to an increase in accounts receivable and a decline in accounts receivable turnover rate [8] - As of June 30, 2025, the accounts receivable balance was 146.86 million, with a turnover rate dropping from 8.89 to 5.31 times per year [9] Fundraising Project Concerns - Hengyun Chang's fundraising projects, including a marketing and technical support center and a liquidity supplement project, have raised questions about their necessity [10] - The proposed investment of 120 million for the marketing project is questionable given the low sales expenses historically incurred by the company [11] - The liquidity supplement project of 169 million is also deemed unnecessary, as the company has sufficient cash reserves and no debt [12]